Humalog (insulin lispro) is a prescription medication used to manage blood sugar levels in people with type 1 and type 2 diabetes. Your doctor will determine the appropriate dosage of Humalog based on ...

Humalog (insulin lispro) is a prescription drug that’s prescribed for diabetes in adults and certain children. The drug comes as a liquid solution for subcutaneous injection or intravenous (IV) ...

Humalog (insulin lispro) and Novolog (insulin aspart) are both rapid-acting insulins prescribed for adults and children with type 1 or type 2 diabetes. They help manage blood sugar (blood glucose) by ...

NovoLog (insulin aspart) and Humalog (insulin lispro) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in certain ...

The change comes on the heels of hearings in Congress where insulin costs were held up for scrutiny. Eli Lilly, under fire for soaring insulin prices, today announced it will introduce an “authorized ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

One of the most commonly used insulins just got a price cut. Drugmaker Eli Lilly said on Monday that it will make an "authorized generic" version of the life-saving diabetes medication Humalog, and ...

INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by ...

A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. The company announced its plans in March amid growing ...

Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. At 50% the price of Humalog, ...

With Congress railing against rising list prices for insulin, Eli Lilly made a commitment to introduce a cheaper generic version of its Humalog in a show of good faith. Consider that a promise kept.